1. 492PA multicenter phase II trial to evaluate the efficacy of mFOLFOX6+cetuximab as induction chemotherapy to achieve R0 surgical resection for advanced colorectal liver metastases (NEXTO trial). (23rd October 2018) Authors: Nishioka, Y; Hasegawa, K; Saiura, A; Oba, M; Yamamoto, J; Nomura, Y; Takayama, T; Hashiguchi, Y; Shibasaki, M; Sakamoto, H; Yamagata, S; Aoyanagi, N; Kaneko, H; Koyama, H; Miyagawa, S; Mise, Y; Shinozaki, E; Yoshida, S; Nozawa, H; Kokudo, N Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗